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Ab s t r Ac t
Snake envenomation is a major cause of death and morbidity in many developing countries. Leptadenia hastata (Pers.) Decne (Asclepiadaceae) 
has been reportedly used in traditional medicine as an antivenom, antiulcer, antidiabetic, analgesic, cardiovascular disorders, bacterial and 
viral infections. This research design is to investigate the phytochemical analysis and phospholipase A2 enzyme inhibition potential of L. hastata 
leaf and stem bark extracts using standard procedures. Preliminary phytochemical screening revealed the presence of key constituents such 
as carbohydrates, tannins, flavonoids, alkaloids, triterpenes, steroids, saponins, and diterpenes. The methanol leaf and stem extracts were able 
to inhibit the hydrolytic action of phospholipase A2 enzyme in a concentration-dependent manner. The research findings lay credence to the 
folkloric claim of the leaf and stem of L. hastata as an anti-snake venom.
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In t r o d u c t I o n
Natural products from medicinal plants, either as pure compounds 
or as standardized extracts, provide unlimited opportunities for 
new drug discoveries due to the unmatched availability of chemical 
diversity.[1] It has been estimated that approximately over half of 
the pharmaceuticals in clinical use today are derived from natural 
products.[2] Some natural product-derived drugs that are a hallmark 
of modern pharmaceutical care include quinine, theophylline, 
penicillin G, morphine, paclitaxel, digoxin, vincristine, doxorubicin, 
cyclosporine, and vitamin A among many other examples.[2] 
For centuries, natural substances, particularly plants, have been 
used to control and treat diseases and this has culminated in the 
discovery of the majority of modern pharmaceutical agents.[3]
Leptadenia hastata (Pers.) Decne a member of the 
Asclepiadaceae family are mostly herbs and shrubs with white sap 
comprising about 250 genera and 2,000 species, many of which 
are lianous and some cactus-like succulents with reduced leaves.[4] 
L. hastata is referred locally in Nigeria as ‘‘yahdiya’’ in Hausa and 
as ‘‘hagalhadjai’’ in Arabic. The plant leaves are used traditionally 
in the management of various ailments such as onchocerciasis,[5] 
scabies,[6] hypertension, catarrh, skin diseases, wound healing, 
snakebite, and prostate complaint.[7]
Snakebite is a major cause of morbidity and mortality in Nigeria, 
especially in rural areas, where large numbers of envenoming 
and deaths are yearly reported. Venom from snake bite is largely 
composed of many complex compounds such as proteins, enzymes, 
neurotoxins, coagulants, anticoagulants, and other substances with 
cytotoxic effects. The venom is water-soluble, has a specific gravity 
of 1.03, and is acidic in nature.[8] Phospholipase A2 enzyme (PLA2E) 
is known to stimulate the phospholipid membrane releasing 
arachidonic acid causing inflammation and pain at the bite site.[9] 
Snake venom is hemotoxic, mainly affecting the circulatory system 
and muscular system, causing excessive scarring, hemorrhagic, 
coagulant defects, hypovolemic shock, pyrogen reaction, and 
serum sickness.[10,11] These side effects are largely due to the action 
of high concentrations of non-immunoglobulin proteins present 
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in commercially available hyperimmune antivenom[12] as well as 
the problem of storage and short expiry dates restrict its usage. 
Snake venom antiserum or antivenom serum (AVS) is associated 
with administration problems with the exact dosage presenting 
a serious problem. AVS administration is also equally associated 
with hypersensitivity reactions, which requires further medical 
research.[13] Over the years, many attempts have been made for the 
development of snake venom antagonists, especially from plants 
sources;[14] hence, this study explores the antivenom efficacy of 
Leptadenia hastate, namely, its PLA2 activity as a potential snakebite 
envenomation to scientifically or otherwise lay credence to its use 
in Nigeria folklore [Figure 1].
MAt e r I A l s A n d Me t h o d s
Collection and Identification of Plant Materials
The leaves and stem of L. hastate were collected in July 2019 
from Dange town, Dange Shuni local government area of Sokoto 
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State, Nigeria. They were authenticated at the herbarium unit, 
Department of Pharmacognosy and Ethnomedicine, Usmanu 
Danfodiyo University Sokoto, Nigeria, where herbarium specimens 
were deposited and voucher numbers PCG/UDUS/894 and 
PCG/UDUS/895 were issued. The samples were shade dried at 
room temperature for 10 days, reduced to a fine powder using 
mortar and pestle, labeled and stored in an airtight glass container 
until ready for use.
Extraction of Plant Materials
The powdered leaves (84.23 g) and stem (64.42 g) of L. hastata were 
cold macerated using absolute methanol for 48 h. The extracts 
were concentrated using a rotary evaporator at 40°C at reduced 
pressure. The residues referred to as the methanol leaf and stem 
extracts were obtained and coded MEL and MES, respectively.
Preliminary Phytochemical Screening
Chemical tests were carried out on the MEL and MES extracts 
to identify the presence of various phytoconstituents such as 
alkaloids, flavonoids, and tannins, among others using standard 
procedures.[15-18]
Snake Venom Sample
The venom sample of Naja nigricollis was obtained from Dr. Amina 
Yusuf Jega of the Department of Pharmaceutical and Medicinal 
Chemistry, Faculty of Pharmaceutical Sciences, Usmanu Danfodiyo 
University Sokoto. The venom with a lethal dose 99 value of 2.75 
mg/kg was preserved in a desiccator at 8°C until ready for use. The 
venom was dissolved in 0.9% saline and centrifuged at 2000 rpm 
for 10 min. The venom concentration was expressed in terms of 
dry weight (mg/mL)
Inhibition of Venom PLA2 Activity
Acidimetric assay for PLA2, as described by Tan and Tan,
[19] was 
adopted. Constant volumes of a substrate comprising calcium 
chloride (18 mM), sodium deoxycholate (8.1 mM), and egg yolk 
were mixed and stirred for 10 min to produce a homogeneous egg 
yolk suspension. Using 1 M sodium hydroxide solution, the pH of 
the suspension was adjusted to 8.0. 0.1 mL of the snake venom 
(0.1–8 mg) was added each to 15 mL to initiate the process of 
hydrolysis. About 0.9% normal saline was used as the negative 
control. The pH of the suspension was observed after 2 min using 
a pH meter. While a 1.0 unit pH decline corresponds to 133 µmol 
fatty acids released in the egg yolk mixture, the enzymatic activity 
of PLA2 was recorded in micromoles of fatty acids released/minute.
To test, the anti-snake venom potential of L. hastate. 
0.1 mg of the snake venom was pre-incubated with 0.1–0.6 mg/mL 
concentration of the extracts to neutralize the hydrolytic action of 
PLA2. The protection offered by the extracts that were calculated 
and represented in terms of percentage using the following 
expressions:
 
ì mol of fatty acid  released
Enzyme activity 
Time taken in minute
=  (1)
Enzyme activity of the test sample
% Antivenom activity 100
Enzyme activity of the control
= ×
 (2)
% Enzyme inhibition activity = 100−Enzyme activity (3)
re s u lts A n d dI s c u s s I o n
Percentage Yield
The result of the extraction yield of the leaves and stem bark of 
L. hastate with respect to the quantity macerated is presented in 
Table 1.
Phytochemical Screening
The preliminary phytochemical screening of the MEL and MES of L. 
hastate showed the presence of important secondary metabolites 
which are presented in Table 2.
The preliminary phytochemical screening revealed the 
presence of various bioactive phytoconstituents. The result 
of phytochemical screening of the MEL and MES revealed the 
presence of polyphenol (tannins, saponin, and flavonoids). This 
suggests that L. hastate leaf and stem extracts have anti-snake 
venom activities since polyphenols have been established to 
possess protein – binding and enzyme inhibiting properties, which 
could invariably inhibit snake venom PLA2 activities, an enzyme 
presents in cobra venom.[20]
Antivenom Assay
The result of the PLA2 of the snake venom when challenged with 
the MEL and MES extracts of L. hastatais presented in Table 3.
PLA2 assay is an important assay mainly used to test for the 
anti-snake venom of plant extracts. In this assay, the enzyme was 
hydrolysed and free fatty acids were released in the presence of 
Table 1: Extraction yield of the plant extracts
Part used Quantity 
macerated (g)
Volume of 
methanol 
used (mL)
Weight of 
obtained 
extract (g)
% yield
Leaves 84.23 750 16.10 19.12
Stem 64.20 750 21.05 32.80Figure 1: Naja nigricollis in a typical habitat
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sodium deoxycholate. N. nigricollis venom was found to liberate 
fatty acids, which was measured in terms of a decrease in pH of 
egg yolk suspension. While the MES were inhibited the hydrolytic 
action of PLA2 enzyme in a concentration-dependent manner with 
48, 50, and 51% inhibition at 0.1, 0.3, and 0.6 mg/mL, MEL had an 
inhibition of 48, 51, and 53% at 0.1, 0.3, and 0.6 mg/mL. This shows 
a slightly better anti-snake venom activity of MEL compared to 
MES at the highest investigated dose. These results significantly 
blocked many of the toxic effects of N. nigricollis venom in vitro. 
This is possible due to the extracts acting through a mechanistic 
intervention rather than a direct physical interaction with the 
venom in vitro as this is similar to the mode of action of many 
polyphenolic compounds found in plant extracts.[21]
This result is in agreement with the report of Ode and 
Asuzu[22] who used different venom concentrations different from 
that reported in this research with the results following the same 
trend, although snake venom neurotoxin content varies both 
qualitative and quantitative from region to region within the 
same species.[23,24] Further, research is currently being advanced 
in the fractionation assay of the L. hastate extract to identify the 
component(s) responsible for the inhibitory effect reported.
co n c lu s I o n
The present findings validate the tradomedicinal application 
of L. hastate as an anti-snake, particularly N. nigricollis venom. 
The plant extracts were significantly effective in neutralizing 
the main toxic and enzymatic effects of N. nigricollis venom. The 
antivenom properties of both plant extracts were potent enough 
to neutralize the lethality and various pharmacological activities of 
N. nigricollis venom. This activity is corroborated with the diverse 
phytoconstituents revealed to be present in the plant materials. 
The plant could serve as therapy for patients with snakebite 
envenomation.
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